| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Evommune, Inc. | Chief Scientific Officer | Common Stock | 49,578 | $884,471 | $17.84 | 09 Dec 2025 | Direct |
| Evommune, Inc. | Chief Scientific Officer | Employee Stock Option (Right to Buy) | 179,619 | 05 Nov 2025 | Direct | ||
| Evommune, Inc. | Chief Scientific Officer | Series B Preferred Stock | 0 | 07 Nov 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000209201725000009-patel-jeegar-pravinkumar-2025-12-09 | Evommune, Inc. | 09 Dec 2025 | 1 | -$134,032 | 4 | Chief Scientific Officer | 11 Dec 2025, 16:22 |
| /report/000209201725000007-patel-jeegar-pravinkumar-2025-11-07 | Evommune, Inc. | 07 Nov 2025 | 2 | $0 | 4 | Chief Scientific Officer | 12 Nov 2025, 16:21 |
| /report/000209201725000005-patel-jeegar-pravinkumar-2025-11-05 | Evommune, Inc. | 05 Nov 2025 | 1 | $0 | 4 | Chief Scientific Officer | 07 Nov 2025, 16:15 |
| /report/000209201725000003-patel-jeegar-pravinkumar-2025-11-05 | Evommune, Inc. | 05 Nov 2025 | 0 | $0 | 3 | Chief Scientific Officer | 05 Nov 2025, 20:09 |